As of 2024-12-12, the Relative Valuation of Cosmo Pharmaceuticals NV (COPN.SW) is 21.52 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 60.50 CHF, the upside of Cosmo Pharmaceuticals NV based on Relative Valuation is -64.4%.
The range of the Relative Valuation is 2.16 - 56.45 CHF.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 14.0x | 10.1x |
| Forward P/E multiples | 12.0x - 16.1x | 13.1x |
| Fair Price | 2.16 - 56.45 | 21.52 |
| Upside | -96.4% - -6.7% | -64.4% |
| Date | P/E |
| 2024-12-10 | 13.14 |
| 2024-12-09 | 13.25 |
| 2024-12-06 | 13.38 |
| 2024-12-05 | 13.40 |
| 2024-12-04 | 13.62 |
| 2024-12-03 | 13.58 |
| 2024-12-02 | 13.53 |
| 2024-11-29 | 13.79 |
| 2024-11-28 | 13.73 |
| 2024-11-27 | 13.68 |
| 2024-11-26 | 13.68 |
| 2024-11-25 | 13.79 |
| 2024-11-22 | 13.71 |
| 2024-11-21 | 13.51 |
| 2024-11-20 | 13.62 |
| 2024-11-19 | 13.64 |
| 2024-11-18 | 13.68 |
| 2024-11-15 | 13.88 |
| 2024-11-14 | 14.12 |
| 2024-11-13 | 14.19 |
| 2024-11-12 | 13.97 |
| 2024-11-11 | 14.08 |
| 2024-11-08 | 14.08 |
| 2024-11-07 | 14.23 |
| 2024-11-06 | 14.10 |
| 2024-11-05 | 14.23 |
| 2024-11-04 | 14.58 |
| 2024-11-01 | 14.86 |
| 2024-10-31 | 14.60 |
| 2024-10-30 | 14.88 |
| 2024-10-29 | 15.23 |
| 2024-10-28 | 15.23 |
| 2024-10-25 | 15.47 |
| 2024-10-24 | 15.69 |
| 2024-10-23 | 15.69 |
| 2024-10-22 | 15.76 |
| 2024-10-21 | 15.84 |
| 2024-10-18 | 16.08 |
| 2024-10-17 | 16.28 |
| 2024-10-16 | 16.30 |
| 2024-10-15 | 16.39 |
| 2024-10-14 | 16.26 |
| 2024-10-11 | 16.33 |
| 2024-10-10 | 16.37 |
| 2024-10-09 | 16.33 |
| 2024-10-08 | 16.33 |
| 2024-10-07 | 16.30 |
| 2024-10-04 | 16.50 |
| 2024-10-03 | 16.24 |
| 2024-10-02 | 16.24 |